Skip to search formSkip to main contentSkip to account menu

Rechallenge

Reintroduction of previously withdrawn medical intervention in the same patient.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Study Type – Therapy (case series) 
Review
2008
Review
2008
CONTEXT A recent meta-analysis suggests that the addition of oxaliplatin or cisplatin to gemcitabine can lead to improved… 
2004
2004
Approximately 40% of patients who receive lepirudin for 5–10 days develop antihirudin antibodies. These antibodies lead to… 
2002
2002
Mycophenolate mofetil (MMF) is increasingly used for prevention of allograft rejection and to treat immune disorders. We report… 
1987
1987
Two-hundred seventy-three node-positive primary breast cancer patients with positive estrogen or progesterone receptors were… 
1979
1979
Neutropenia associated with high-dose cimetidine therapy developed in a patient in whom earlier therapy, as well as rechallenge…